Molecular structure pattern

Neuroendocrine Tumors References

Last updated: 20 October 2026
Reviewed by
  1. MedWormhttp://www.medworm.com/rss/index.php/Gastroenterology/17/http://www.medworm.com/rss/medicalfeeds/specialities/Gastroenterology.xml
  2. MedWormhttp://www.medworm.com/rss/index.php/Endocrinology/15/http://www.medworm.com/rss/medicalfeeds/specialities/Endocrinology.xml
  3. MedWormhttp://www.medworm.com/rss/index.php/Cancer-%26-Oncology/6/http://www.medworm.com/rss/medicalfeeds/specialities/Cancer-Oncology.xml
  4. American Cancer Society. Gastrointestinal carcinoid tumor stages. American Cancer Society website. https://www.cancer.org. Dec 2017.
  5. National Comprehensive Cancer Network. Neuroendocrine and adrenal tumors. Version 2.2018. NCCN. https://www.nccn.org/. May 2018.
  6. ClinicalKey. Neuroendocrine tumors of the gastrointestinal tract, lung, and thymus (carcinoid tumors). ClinicalKey. https://www.clinicalkey.com. 23 Jan 2023. Accessed 08 Aug 2023.
  7. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: neuroendocrine and adrenal tumors version 2.2021. NCCN. http://www.nccn.org. 18 Jun 2021.
  8. Pavel M, Öberg K, Falconi M,et al; ESMO Guidelines Committee. Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Jul;31(7):844-860. doi: 10.1016/j.annonc.2020.03.304. Accessed 08. PMID: 32272208
  9. Wolin EM, Jensen RT. Neuroendocrine tumors. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th edition. Philadelphia, PA: Elsevier; 2020. https://www.clinicalkey.com. Accessed 18 Aug 2021:1520-1528.e1.
  10. Baudin E, Caplin M, Garcia-Carbonero R, et al; ESMO Guidelines Committee. Lung and thymic carcinoids: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021 Apr;32(4):439-451. doi: 10.1016/j.annonc.2021.01.003. PMID: 33482246
  11. Halfdanarson TR, Strosberg JR, Tang L, et al. The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of pancreatic neuroendocrine tumors. Pancreas. 2020 Aug;49(7):863-881. doi: 10.1097/MPA.0000000000001597. Accessed 28 Mar 2022. PMID: 32675783
  12. Strosberg JR. Treatment of the carcinoid syndrome. UpToDate. https://www.uptodate.com/. Feb 2022.
  13. Thomas CF, Jett JR, Strosberg JR. Lung neuroendocrine (carcinoid) tumors: Epidemiology, risk factors, classification, histology, diagnosis, and staging. UpToDate. https://www.uptodate.com/. Jul 2021.
  14. Allendorf J, Chabot J. Surgical resection of sporadic pancreatic neuroendocrine tumors. UpToDate. https://www.uptodate.com. Jun 2023.
  15. Chan J, Kulke M, Clancy T. Metastatic well-differentiated pancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion. UpToDate. https://www.uptodate.com. Jun 2023.
  16. Das S, Al-Toubah T, Strosberg J. Chemotherapy in neuroendocrine tumors. Cancers (Basel). 2021 Sep;13(19):4872. doi: 10.3390/cancers13194872. PMID: 34638356
  17. Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. PMID: 35294740
  18. Sorbye, H, Grande E, Pavel M, et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma. J Neuroendocrinol. 2023 Mar;35(3):e13249. doi: 10.1111/jne.13249. Accessed 08 Aug 2023
  19. Strosberg J, Del Rivero J. Overview of tumor biomarkers in gastroenteropancreatic neuroendocrine tumors. UpToDate. https://www.uptodate.com. Jun 2023.
  20. Strosberg J, Gangi A. Staging, treatment, and post-treatment surveillance of non-metastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors. UpToDate. https://www.uptodate.com. Jun 2023.
  21. Yang Z. Pathology, classification, and grading of neuroendocrine neoplasms arising in the digestive system. UpToDate. https://www.uptodate.com. Jun 2023.
  22. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): neuroendocrine and adrenal tumors. Version 2.2024. NCCN. https://www.nccn.org/. 01 Aug 2024.
  23. National Institute for Health and Care Excellence (NICE). Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver. NICE. https://www.nice.org.uk/. 16 May 2024.
  24. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): neuroendocrine and adrenal tumors. Version 2.2025. NCCN. https://www.nccn.org/. 28 May 2025.
  25. Rossi RE, Massironi S. The increasing incidence of neuroendocrine neoplasms worldwide: current knowledge and open issues. J Clin Med. 2022 Jun;11(13):3794. doi: 10.3390/jcm11133794. PMID: 35807078
  26. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): neuroendocrine and adrenal tumors. Version 1.2026. NCCN. https://www.nccn.org/. 21 Apr 2026.
  27. Spada F, Gelsomino F, Rinzivillo M, et al. Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET). ESMO Open. 2025 Nov;10(11):105878. doi: 10.1016/j.esmoop.2025.105878. PMID: 41223791